Maito, Alfhaiser M.

HRN: 16-23-02  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2023
METRONIDAZOLE 500MG (TAB)
05/28/2023
06/05/2023
ORAL
500mg
Tid
Thickly MSAF
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: